Literature DB >> 14621080

CARD15 gene mutations in sarcoidosis.

M Schürmann1, R Valentonyte, J Hampe, J Müller-Quernheim, E Schwinger, S Schreiber.   

Abstract

Sarcoidosis, Blau syndrome and Crohn's disease are complex disorders, characterised by granulomatous inflammation affecting a variety of organs. Mutations of the CARD15 gene, on chromosome 16, have been shown to contribute significantly to Crohn's disease and to cause Blau syndrome. These factors prompted the current authors to study CARD15 mutations in sarcoidosis. A total of 138 families were genotyped, including 302 patients with sarcoidosis and 127 patients without a family history of sarcoidosis (together with their parents), for four main coding CARD15 polymorphisms associated with increased risk of Crohn's disease. Furthermore, the gene segment that harbours Blau syndrome mutations was sequenced in 39 selected patients from 39 families with affected siblings identical for one or two parental chromosomes 16s and in eight patients from multi-case families. None of the reported Blau syndrome mutations and no new sequence alterations were found. There was an increased frequency of transmission of the rare allele of the polymorphic sites 802C>T (SNP5) and 2722G>C (SNP12) in at least one of the two study groups. In conclusion, CARD15 mutations, which are important in Crohn's disease and Blau syndrome, play no major role in sarcoidosis in this study population. However, these mutations could be of limited importance, especially in patients without a family history of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14621080     DOI: 10.1183/09031936.03.00040602

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  27 in total

Review 1.  Blau syndrome and related genetic disorders causing childhood arthritis.

Authors:  Mara L Becker; Carlos D Rose
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

Review 2.  Genetics of sarcoidosis: candidate genes and genome scans.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Proc Am Thorac Soc       Date:  2007-01

3.  Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease.

Authors:  Steven M Chirieleison; Rebecca A Marsh; Prathna Kumar; Joseph K Rathkey; George R Dubyak; Derek W Abbott
Journal:  J Biol Chem       Date:  2017-04-12       Impact factor: 5.157

Review 4.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

5.  Familial early onset sarcoidosis with bone cysts and erosions.

Authors:  Norbert Blank; Regina Max; Frank Autschbach; Martin Libicher; Hanns-Martin Lorenz
Journal:  Skeletal Radiol       Date:  2007-05-11       Impact factor: 2.199

6.  Evolution of Crohn's disease-associated Nod2 mutations.

Authors:  Christoph Gasche; Manuela Nemeth; Paul Grundtner; Claudia Willheim-Polli; Peter Ferenci; Robert Schwarzenbacher
Journal:  Immunogenetics       Date:  2008-02-06       Impact factor: 2.846

Review 7.  The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.

Authors:  Ivan Tattoli; Leonardo H Travassos; Leticia A Carneiro; Joao G Magalhaes; Stephen E Girardin
Journal:  Semin Immunopathol       Date:  2007-08-10       Impact factor: 9.623

8.  Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis.

Authors:  Igor Medica; Andrej Kastrin; Ales Maver; Borut Peterlin
Journal:  J Hum Genet       Date:  2007-09-04       Impact factor: 3.172

Review 9.  NOD2/CARD15 gene polymorphisms and sarcoidosis susceptibility: review and meta-analysis.

Authors:  Xuping Chen; Zhenxing Zhou; Yi Zhang; Xiaoliang Cheng; Xiaowen Guo; Xiaodong Yang
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

10.  [Genetic risk profile of sarcoidosis].

Authors:  A Fischer; G Zissel; A Nebel; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2014-02       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.